» Articles » PMID: 23082935

Hepatitis B and C Infection in Haemodialysis Patients in Libya: Prevalence, Incidence and Risk Factors

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2012 Oct 23
PMID 23082935
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients receiving maintenance haemodialysis (HD) are at higher risk for acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general population. Strict infection control measures are essential to prevent nosocomial transmission. We aimed to investigate the incidence and prevalence of HBV and HCV infection in the HD population of Libya as well as risk factors for infection.

Methods: All adult patients receiving maintenance HD (n=2382) in Libyan dialysis centres (n=39) were studied between May 2009 and October 2010. Testing for Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies was performed at initiation of dialysis and every 3-6 months thereafter. Patients who were sero-negative for HBV and HCV (n=1160) were followed up for 1 year to detect sero-conversions.

Results: Participant median age was 49 years and 58% were male. 831 patients (34.9%) were sero-positive for HBV and/or HCV (anti-HCV positive 31.1%; HBsAg positive 2.6%; both positive 1.2%). Of the sero-positive patients 4.7% were known to be infected before the initiation of HD. The prevalence of HBV±HCV infection varied widely between HD centres from 0% to 75.9%. Sero-positive patients were younger, had longer time on dialysis and more previous blood transfusions. Prospective follow-up revealed an incidence of sero-conversion of 7.7% during 1 year (7.1% HCV; 0.6% HBV). Wide variation in rates of newly acquired infections was observed between dialysis centres. All new HBV cases were referred from centres already treating HBV infected patients. New HCV infections were reported in most centres but the rate of HCV sero-conversion varied widely from 1.5% to 31%. Duration of dialysis, history of previous renal transplant and history of receiving HD in another centre in Libya were significantly associated with sero-conversion.

Conclusion: Patients on maintenance HD in Libya have a high incidence and prevalence of HCV infection and lower rates of HBV infection. The factors associated with HBV and HCV infection are highly suggestive of nosocomial transmission within HD units. Urgent action is required to improve infection control measures in HD centres and to reduce dependence on blood transfusions for the treatment of anaemia.

Citing Articles

Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana.

Dzudzor B, Nsowah K, Agyemang S, Vento S, Amarh V, Boima V PLoS One. 2024; 19(3):e0290917.

PMID: 38437229 PMC: 10911607. DOI: 10.1371/journal.pone.0290917.


Hepatitis C Seroconversion Remains High among Patients with Regular Hemodialysis: Study of Associated Risk Factors.

Dharmesti N, Wibawa I, Kandarini Y Int J Hepatol. 2023; 2022:8109977.

PMID: 36618760 PMC: 9815928. DOI: 10.1155/2022/8109977.


Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in Somalia.

Jeele M, Addow R, Nur Adan F, Jimale L Int J Nephrol. 2021; 2021:1555775.

PMID: 34812291 PMC: 8605903. DOI: 10.1155/2021/1555775.


Updated Evidence on the Epidemiology of Hepatitis C Virus in Hemodialysis.

Fabrizi F, Cerutti R, Messa P Pathogens. 2021; 10(9).

PMID: 34578181 PMC: 8468134. DOI: 10.3390/pathogens10091149.


The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis.

Adane T, Getawa S PLoS One. 2021; 16(6):e0251570.

PMID: 34157037 PMC: 8219139. DOI: 10.1371/journal.pone.0251570.


References
1.
Souqiyyeh M, Al-Attar M, Zakaria H, Shaheen F . Dialysis centers in the kingdom of saudi arabia. Saudi J Kidney Dis Transpl. 2008; 12(3):293-304. View

2.
Mostaghni A, Soltanian A, Mokhtari E, Japoni S, Mehrabani D . Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3):200-2. PMC: 3206679. View

3.
Mohamed W . Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center. Saudi J Kidney Dis Transpl. 2010; 21(3):548-54. View

4.
Jemni S, Ikbel K, Kortas M, Mahjoub J, Ghachem L, BIDET J . Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv Rev Fr Hematol (1978). 1994; 36(5):349-51. View

5.
Alashek W, McIntyre C, Taal M . Provision and quality of dialysis services in Libya. Hemodial Int. 2011; 15(4):444-52. DOI: 10.1111/j.1542-4758.2011.00588.x. View